CBCRP Funded Projects Abstracts: Initial, Progress, and Final Reports
The CBCRP wants to make our funded research accessible to both the public and breast cancer researchers. We encourage researchers to examine this portfolio and find new, unexplored topics to address in applications to the Program. We analyze applications that are eligible for funding each year to best select those topics that will diversify our portfolio. Our goal is to produce a body of research that is unique to California, represents the diversity in population and research interests of our State, and limits duplication of effort with other funding agencies.
CBCRP's Research Priority Issues:
The CBCRP's advisory Breast Cancer Research Council has organized our requests for applications and the funded portfolio into four broad priority issues with nine major topic areas:
The Community Impact of Breast Cancer
- Health Policy and Health Services: Better Serving Women's Needs
- Racial/Ethnic Differences: Eliminating Disparity
- Sociocultural, Behavioral and Psychological Issues Relevant to Breast Cancer: The Human Side
Etiology and Prevention: Finding the Underlying Causes
Biology of the Breast Cell: The Basic Science of the Disease
Detection, Prognosis, and Treatment: Delivering Clinical Solutions
Our funded portfolio and abstracts are organized according to this scheme, and within some topics we have added sub-topics to provide a more useful display. You can scan these lists by funding year and select individual grants to find more detailed information, abstracts, and publications. In addition, we have a PI alphabetical listing to provide an alternate way of accessing each project.
An alternate way of examining our portfolio is to refer to the Awards Compendia, which organizes each year's funded grants by Priority Issue and lists the recipient institution and award amount.
Individual Grant Information
The grant abstracts are prepared by the principal investigator(s) and edited by the CBCRP. The Initial Award Abstract outlines the background, research topic, goals, methods to be used, and possible impact. Each year the principal investigator(s) submit a Progress Report abstract that updates the project. The Final Report abstract summarizes the accomplishments for the entire funded period. When a final abstract is present, then we remove the progress report entries.
For grants that have contributed to publications, we have placed the citation and link to the National Library of Medicine's PubMed listing at the end of the abstract page.
The CBCRPoffers several types of funding which vary according to research aims, the career level of the principal investigator, and other characteristics. Some of these award types have been discontinued and some are fairly recent.
CRC (Community Research Collaboration) Pilot and Full Awards
Offered from 1997-present. An up to 18-month (Pilot) or up to three-year (Full Research) project to link breast cancer-focused community groups and organizations with traditional research (e.g., university, hospital, or foundation) partners to investigate breast cancer topics of interest to both partners.
- Joining Forces Conference Awards
Offered since 2001. An up to $25,000 grant to support a conference, symposium, retreat, or other structured meeting to link breast cancer researchers, non-breast cancer investigators, and community members for the purpose of stimulating new ideas and collaborations—specifically those related to the collaborative award types.
Innovative Investigator-initiated Awards:
- IDEA (Innovative, Developmental, and Exploratory Awards)
For a one-year (IDEA-I from 1995 to 2000), two-year (IDEA-II from 1997 to 2000), or 18-month (IDEA since 2001) project that explores novel experimental approaches that are high risk/high reward. Researchers without preliminary data in breast cancer can receive funding for a promising research IDEA.
- Translational Research Award
Translational Research Awards were launched in 2007. They are three year awards that fund projects that put prior research knowledge to practical use in the patient or community setting.
Discontinued Award Types
Introduced in 2003. Up to a two-year project for masters- or doctoral-level graduate students who wish to pursue breast cancer-related research. Discontinued after 2010.
- Postdoctoral Fellowship
Offered since 1995. Up to a two-year project for additional training of new Ph.D. and M.D. researchers under the direction of a mentor. Serves to increase the pool of outstanding young breast cancer researchers. Discontinued after 2010.
- SPRC (Scientific Perspectives Research Collaboration) Exploratory and Full Awards
Offered from 2000 to 2004. An up to 18-month (Exploratory) or up to three-year (Full Research) project that allows breast cancer researchers to team-up with non-breast cancer investigators. The aim is to introduce new disciplines and approaches not yet engaged in the fight against breast cancer. Discontinued after 2004 (Cycle X).
- TRC (Translational Research Collaboration) Pilot and Full Awards
Offered from 1997 to 2004. An up to 18-month (Pilot) or up to three-year (Full Research) project for a cross-disciplinary team approach for translation of breast cancer research in the therapeutic, clinical areas, or healthcare and support areas. Creates the opportunity for clinical, basic science, epidemiological, and social-behavioral scientists to team-up. Discontinued after 2004 (Cycle X).
- Research Project
Offered from 1995 to 1996. An up to a three-year grant that can focus on any Priority Issue. Discontinued after 1996, and replaced by topic-targeted RFAs.
- RFA (Request for Applications)
Offered from 1996 to 2004. An up to a three-year project that focuses on specific topics including, Biology of the Normal Breast, Prevention and Risk Reduction, Sociocultural, Behavioral, and Psychological Issues, and Health Policy and Health Services. This award type allows the CBCRP to directly target under-funded research areas. Discontinued after 2004 (Cycle X).
- STEP Award
Introduced in 2001 and replaced the IDEA-II. An up to two-year project with preliminary data in breast cancer. Discontinued after 2004 (Cycle X).
Offered from 1995 to1997, then replaced by the IDEA-II and STEP. Up to a two-year project specifically focused on translation of research in either the Innovative Treatment and Models of Care priority issues. The focus is on translation and testing pre-clinical applications.
- New Investigator
Offered from 1995 to 2004. Up to a three-year project to support a researcher starting an independent career in breast cancer research. Discontinued after 2004 (Cycle X). Junior investigators are encouraged to apply under the IDEA award type.
- Career Enrichment
Offered from 2002 to 2004. A one-year project for an established researcher or clinician to gain experience in a new breast cancer field under the direction of a colleague/mentor.
- Training Program
Offered from 1995 to 2004. Up to a three-year award to an educational institution for the training of new breast cancer researchers at the undergraduate and/or graduate levels.